Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Francini

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
British Journal of Cancer|September 1, 1996
A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancerA Piga, S Cascinu, L Latini, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a phase Ib clinical trialP Correale, G Campoccia, K Y Tsang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2010
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patientsB Vincenzi, S Galluzzo, D Santini, et al.
Oncology Reports|June 21, 2006
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patientsP Correale, D Cerretani, C Remondo, et al.
British Journal of Cancer|July 17, 2003
A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acidP Correale, S Messinese, S Marsili, et al.
British Journal of Cancer|January 22, 2004
UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancerR Petrioli, M Sabatino, A I Fiaschi, et al.
British Journal of Cancer|May 20, 2004
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinomaP Correale, S Messinese, M Caraglia, et al.
Journal of Chemotherapy (Florence, Italy)|January 5, 2002
In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthaseP Correale, M Sabatino, M G Cusi, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
British Journal of Cancer|September 1, 1996
A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancerA Piga, S Cascinu, L Latini, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a phase Ib clinical trialP Correale, G Campoccia, K Y Tsang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2010
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patientsB Vincenzi, S Galluzzo, D Santini, et al.
Oncology Reports|June 21, 2006
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patientsP Correale, D Cerretani, C Remondo, et al.
British Journal of Cancer|July 17, 2003
A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acidP Correale, S Messinese, S Marsili, et al.
British Journal of Cancer|January 22, 2004
UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancerR Petrioli, M Sabatino, A I Fiaschi, et al.
British Journal of Cancer|May 20, 2004
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinomaP Correale, S Messinese, M Caraglia, et al.
Journal of Chemotherapy (Florence, Italy)|January 5, 2002
In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthaseP Correale, M Sabatino, M G Cusi, et al.
Pageof 7